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Abstract
The objective of this study was to use data from the Behavioral
Risk Factor Surveillance System (BRFSS) to examine the preval-
ence of multiple chronic conditions (MCC) by select sociodemo-
graphic groups and determine the prevalence of most common
MCC dyads and triads among Delaware adults. Combined data for
2011 through 2014 from BRFSS (n = 18,052) were analyzed to
determine prevalence of MCC. Delaware adults were categorized
as having 0, 1, 2, or 3 or more of the following diagnosed chronic
conditions: angina, arthritis, asthma, cancer, chronic kidney dis-
ease, chronic obstructive pulmonary disease, diabetes, high blood
pressure, high cholesterol, myocardial infarction (heart attack),
obesity, or stroke. More than 65% of Delaware adults had at least
1 of the 12 selected chronic conditions. Furthermore, 36.8% of
Delaware adults had MCC. The arthritis/obesity dyad and the arth-
ritis/high blood pressure/high cholesterol triad were the 2 most
prevalent MCC combinations. The findings of this study contrib-
ute information to the field of MCC research.
Introduction
Chronic conditions,  which affect  millions of  Americans every
year, largely spring from a small set of common risk factors such
as smoking, physical inactivity, unhealthy diet, and excessive al-
cohol consumption (1). Because of this interrelatedness, more and
more people are living with not just 1 chronic condition but with 2
or more conditions (2,3). By definition, chronic conditions are
conditions that last a year or more and require ongoing medical at-
tention and/or limit activities of daily living (3). They include both
physical conditions and mental disorders. Multiple chronic condi-
tions (MCC) are defined as 2 or more chronic conditions that af-
fect a person at the same time (1–3). Aging is a major nonmodifi-
able risk factor for most chronic conditions (3). As the US popula-
tion ages and life expectancy increases, the number of people with
MCC is expected to rise (2,3). People with MCC have a greater
risk of dying prematurely and have increased hospitalizations and
activity limitations (2,3).  The prevalence of MCC needs to be
monitored over time to understand patterns of disease and identify
constellations of conditions that are most prevalent (4). Identify-
ing the most common patterns of MCC can support public health
professionals and health care providers in coordinating and man-
aging care for various subgroups (3,4).
In 2010, the US Department of Health and Human Services (HHS)
provided a strategic framework to improve health care outcomes
of people with MCC (4). The framework proposed a paradigm
shift within the context of how chronic illnesses are addressed in
the  United  States  — from an  approach  focused  on  individual
chronic diseases to one that uses a MCC approach (4). Goal 4 of
the framework emphasizes the importance of research to under-
stand the epidemiology of MCC. Objectives of the framework in-
clude research stimulation to elucidate differences in MCC among
various sociodemographic groups. Additional research is needed
to identify the most common MCC dyads and triads (3,4). Re-
search findings would fill  knowledge gaps on MCC and assist
public health programs in addressing the health care needs of the
population with MCC (4,5).
MCC research has been increasing. In October 2012, the Centers
for Medicare and Medicaid Services reported the prevalence of
MCC among Medicare beneficiaries (6). Two of 3 Medicare bene-
ficiaries were found to have MCC, accounting for 93% of total
Medicare expenditures (6). In another study, National Health In-
terview Survey (NHIS) data were analyzed to examine the preval-
ence of MCC by selected sociodemographic groups; these data
showed a MCC prevalence of 26% among adults (7).
Bolstering MCC research efforts at the state and local level will
further strengthen the strategic framework proposed by HHS. Loc-
al data will support improved characterization of the MCC popula-
tion and facilitate state health care providers and regional policy
makers in coordinating and managing care for people with MCC
(4–7).
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This article presents findings on MCC in Delaware using Behavi-
oral Risk Factor Surveillance System (BRFSS) data. The main ob-
jective of this study was to use data from BRFSS to examine the
prevalence of MCC by selected sociodemographic groups and de-
termine the prevalence of most common MCC dyads and triads
among Delaware adults.
Analysis
Data source
BRFSS is a cross-sectional telephone survey of the civilian, nonin-
stitutionalized adult population aged 18 years or older, conducted
by the Centers for Disease Control and Prevention and state health
departments. Established in 1984 in 15 states, BRFSS now col-
lects data on health-related risk behaviors, chronic health condi-
tions, and use of preventive services in all 50 states as well as the
District of Columbia and 3 US territories (8). BRFSS completes
more  than  400,000  adult  interviews  each  year,  making  it  the
largest continuously conducted health survey system in the world.
The BRFSS questionnaire is  designed to include a core set  of
questions used by all states and an additional set sponsored by
each state that may be derived from optional modules developed
by the Centers for Disease Control and Prevention or other appro-
priate sources. By collecting behavioral health risk data at the state
and local level, BRFSS has become a powerful data source for
chronic disease surveillance (8).
Data from 18,052 Delaware adults surveyed during 2011 through
2014  combined  were  analyzed.  BRFSS  response  rates  for
Delaware varied from 37.4% in 2012 to 46.4% in 2014.
Definitions
The HHS Interagency Workgroup on MCC and Office of the As-
sistant  Secretary  for  Health  generated  a  conceptual  model  to
define  chronic  conditions  in  the  United  States  and  provide  a
framework for more consistent application of selected conditions
to multiple data systems (9). The 20 chronic conditions are hyper-
tension, congestive heart failure, coronary artery disease (CAD),
cardiac arrhythmias, hyperlipidemia, stroke, arthritis, asthma, aut-
ism spectrum disorder, cancer, chronic kidney disease, chronic ob-
structive pulmonary disease (COPD), dementia, depression, dia-
betes,  hepatitis,  human immunodeficiency virus,  osteoporosis,
schizophrenia, and substance use disorders. The data systems used
for defining these 20 MCC do not include BRFSS. In addition,
studies on MCC use various numbers and combinations of the 20
recommended  conditions,  with  selections  determined  by  data
availability. For example, studies by the Centers for Medicare and
Medicaid Services used 19 of the recommended 20 conditions,
whereas the NHIS used 10 conditions (6–9).
My analyses used 12 chronic conditions: angina, arthritis, asthma,
cancer, chronic kidney disease, chronic obstructive pulmonary dis-
ease, diabetes, high blood pressure, high cholesterol, myocardial
infarction (heart attack), obesity, and stroke. CAD is listed as one
chronic condition by the HHS Workgroup, but data collection sys-
tems differ in reporting this condition as coronary heart disease,
ischemic heart disease, or other terms. Angina and heart attack
(myocardial  infarction)  are  included  in  the  category  of  CAD.
BRFSS assesses CAD with 2 questions, 1 for angina and 1 for
heart attack. Both variables were included in my analyses to as-
sess CAD.
A 12th condition, obesity, which is not included in the recommen-
ded 20 conditions, was included in my analyses. Obesity has been
identified as a chronic condition or disease in the scientific literat-
ure (10). More than one-third of US adults are obese. Obesity-re-
lated chronic conditions include heart disease, stroke, type 2 dia-
betes, high blood pressure, high cholesterol, and certain types of
cancer.  In June 2013,  the American Medical  Association offi-
cially recognized obesity as a disease (11).
Participants were identified as having a diagnosed condition if
they had ever been told by a doctor or other health care provider
that they had high blood pressure, high cholesterol, coronary heart
disease (angina), stroke, diabetes, cancer, kidney disease, COPD,
asthma, arthritis, or heart attack (myocardial infarction). BRFSS
captures data only on conditions that were confirmed by a doctor
or health professional, potentially leading to the underreporting of
conditions that were undiagnosed or were not recalled by the re-
spondent during the BRFSS interview.
For obesity, data on self-reported weight and height was used to
calculate body mass index (BMI) (kg/m2). Participants were clas-
sified as obese if BMI was 30 or higher. Health insurance categor-
ies were based on a hierarchy of mutually exclusive categories,
which were private coverage, public coverage (Medicaid, Medi-
care, others state programs), other coverage (TRICARE [formerly
CHAMPUS], Veterans Affairs, or military health plans; and any
other), and uninsured.
I counted the presence of the 12 selected chronic conditions and
combined them into 4 mutually exclusive categories: 0, 1, 2, and 3
or more chronic conditions. I also generated weighted prevalences
for the 10 most common MCC dyad and triad combinations. The 5
most common MCC dyad and triad combinations were further de-
scribed by sex, age group, and county. These MCC dyad and triad
combinations were also mutually exclusive.
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Statistical analyses
SAS version 9.3 (SAS Institute, Inc) was used to account for the
complex sample design of BRFSS when generating estimates and
confidence intervals. Descriptive estimates were calculated for
subgroups defined by age, sex, race/ethnicity, and health insur-
ance coverage. Two-tailed tests were used to test for significant
differences in prevalence between population subgroups (P < .05).
Three standard BRFSS data suppression guidelines were followed
for the reporting of results: where 1) the numerator was less than
5, 2) the denominator was less than 50, and 3) the confidence in-
terval was more than 20 points wide. If any of these guidelines
were met for a given cell, the results for that cell were suppressed.
Prevalence of MCC by Selected
Sociodemographic Groups
During 2011 through 2014, more than 65% of Delaware adults had
at least 1 of the 12 selected chronic conditions (Table 1); 36.8%
had MCC, with 16.5% having 2 chronic conditions and 20.3%
having 3 or more chronic conditions. The prevalence of MCC var-
ied by sociodemographic group (Table 1).  Women were more
likely than men to have exactly 2 chronic conditions (P = .04) or 3
or more chronic conditions (P = .03). The prevalence of MCC was
higher  among non-Hispanic white  adults  than Hispanic adults
among adults with 2 chronic conditions (P = .04). Among adults
with 3 or more chronic conditions MCC prevalence was higher
both among non-Hispanic whites and non-Hispanic blacks than
among Hispanics (P = .001). The percentage of adults with MCC
(both 2 and 3 or more) increased with age and was higher among
those aged 65 years or older (P < .001). Differences in the preval-
ence of MCC (3 or more) were also found among the 3 counties in
Delaware. Kent and Sussex counties had a higher prevalence than
New Castle had (P < .001). Examination by health insurance cov-
erage status indicated that MCC prevalence was greater among
adults with public coverage than among adults with private or
some other type of coverage.
Prevalence of MCC Dyads and Triads
For Delaware adults with 2 chronic conditions, the MCC dyad
with the highest prevalence was arthritis and obesity (Table 2).
This  dyad  was  also  the  most  common  in  both  sexes,  in  all  3
counties, and in both age groups. The second most prevalent dyad
was high blood pressure and high cholesterol. Table 2 lists the 5
most common dyads by sex, age, and county.
Among Delaware adults with 3 or more chronic conditions, the
MCC triad of arthritis, high blood pressure, and high cholesterol
was the most prevalent (Table 3). This was also the most common
triad in men, those aged 65 or older, and those in New Castle and
Sussex counties. Arthritis, asthma, and obesity was the most com-
mon triad in women, in Kent County, and in those aged less than
65 years. Table 3 lists the 5 most common triads by sex, age, and
county among Delaware adults with 3 or more chronic conditions.
Summary
Nearly 37% of Delaware adults have MCC, based on BRFSS data
from 2011 through 2014. More Delaware adults had 3 or more
chronic conditions (20.3%) compared with those with 2 chronic
conditions (16.5%). Also, these MCC prevalence findings are con-
siderably higher than those in the study using NHIS data (7) be-
cause of differences in the number and type of chronic conditions
studied. Including obesity as one of the chronic conditions may
have been the driving factor. Nearly 31% of Delaware adults were
obese in  2014 (8).  However,  the  general  distribution of  MCC
among sociodemographic groups was similar to that found in pre-
vious research. Among certain subgroups (such as women and
older adults), the prevalence of MCC was generally higher, and
for others (Hispanic adults and those with private insurance) the
prevalence was generally lower. These findings were consistent
with those of earlier studies (6,7). The arthritis/obesity dyad and
the arthritis/high blood pressure/high cholesterol triad were 2 of
the most prevalent MCC combinations, differing from the most
common MCC combinations found in the NHIS study (7).
This study has limitations. BRFSS is a telephone survey that ex-
cludes people living in institutions, nursing homes, long-term care
facilities, and correctional institutions, and results might not be ap-
plicable to these populations. Second, BRFSS data are self-repor-
ted and subject to recall and social desirability bias (eg, underre-
porting of actual weight). Also, BRFSS captures data only on con-
ditions that were confirmed by a doctor or health professional, po-
tentially leading to the underreporting of conditions that were un-
diagnosed  or  were  not  recalled  by  the  respondent  during  the
BRFSS interview. In addition, BRFSS captures data on only 10 of
20 conditions listed in the HHS Interagency Workgroup definition
(4,5). Not all mental health conditions in the list of 20 conditions
are included in the BRFSS Core questionnaires and therefore were
not included in these analyses. Because not all 20 conditions were
included, these analyses most likely underestimate the burden of
MCC.
Despite  these  limitations,  examining  the  prevalence  of  MCC
among subgroups of adults allowed the identification of MCC pat-
terns in the Delaware adult population. Future studies could seek
to explain why differences in the prevalence of MCC among sub-
groups exist. Strategies of the HHS MCC initiative (4,5) include
stimulation of epidemiologic research to understand the patterns of
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MCC. The findings of this study contribute information to the
field of MCC research. In addition, providing MCC data at the
state and county level can improve targeting of interventions by
caregivers and policy makers.
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Tables
Table 1. Prevalence of Chronic Conditionsa Among Delaware Adults by Selected Characteristics, Behavioral Risk Factor Surveillance System, 2011–2014
Characteristic
0 Chronic Conditions,
% (95% CI)
1 Chronic Condition,
% (95% CI)
2 Chronic Conditions,
% (95% CI)
≥3 Chronic Conditions,
% (95% CI)
Total 34.7 (33.6–35.8) 28.5 (27.5–29.5) 16.5 (15.7–17.2) 20.3 (19.6–21.1)
Sex
Male 36.3 (34.6–38.0) 28.6 (27.0–30.2) 15.7 (14.6–16.8) 19.5 (18.3–20.6)
Female 33.3 (31.9–34.6) 28.4 (27.2–29.7) 17.2 (16.2−18.1) 21.1 (20.1–22.1)
Race/ethnicity
White 33.4 (31.6–35.1) 28.9 (27.3–30.6) 17.5 (16.3–18.7) 20.2 (19.0–21.5)
Black 34.7 (30.8–38.7) 26.6 (23.0–30.2) 17.1 (14.2–19.8) 21.7 (18.7–24.6)
Hispanic 55.4 (46.6–64.1) 33.4 (24.6–42.2) 10.7 (6.30–15.1) 11.3 (7.1–15.4)
Age, y
<65 40.3 (39.1–41.6) 29.9 (28.7–31.1) 14.9 (14.1–15.8) 14.9 (14.1–15.6)
≥65 11.9 (10.7−13.1) 22.9 (21.6–24.3) 22.6 (21.2–24.0) 42.6 (41.0–44.2)
County
Kent 31.1 (29.0–32.9) 29.4 (27.5–31.3) 16.9 (15.6–18.4) 22.6 (21.1–24.2)
New Castle 37.1 (35.6–38.7) 29.1 (27.6–30.5) 15.9 (14.9–17.0) 17.9 (16.8–18.9)
Sussex 29.3 (27.4–31.2) 26.6 (24.8–28.4) 18.2 (16.8–19.5) 25.9 (24.4–27.5)
Insurance
Public 22.7 (19.4–26.0) 30.5 (27.1–33.9) 22.1 (19.2–25.0) 24.7 (22.0–27.5)
Private 48.1 (45.0–51.3) 31.9 (28.9–34.9) 12.2 (10.6–13.9) 7.7 (6.4–9.1)
Other 37.9 (28.8–47.2) 26.1 (19.0–33.2) 17.7 (11.1–24.4) 18.2 (12.4–24.1)
Uninsured 33.4 (32.2–34.6) 27.8 (26.6–28.9) 16.7 (15.8–17.5) 22.2 (21.3–23.1)
Abbreviation: CI, confidence interval.
a Angina, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, high blood pressure, high cholesterol, myocardial in-
farction (heart attack), obesity, and stroke.
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Table 2. Most Prevalent Chronic Conditiona Dyads by Age, Sex, and County for Delaware Adults with 2 Chronic Conditions, Behavioral Risk Factor Surveillance Sys-
tem, 2011–2014
Dyad % (95% Confidence Interval)
Total
Arthritis/obesity 15.6 (14.0–17.3)
High blood pressure/high cholesterol 9.1 (7.9–10.3)
Asthma/obesity 8.3 (6.8–9.8)
High blood pressure/obesity 6.5 (5.3–7.6)
Diabetes/obesity 5.4 (4.2–6.6)
Arthritis/asthma 5.3 (4.3–6.4)
Arthritis/high blood pressure 5.2 (4.2–6.2)
Obesity/high cholesterol 4.9 (4.0–5.9)
Arthritis/high cholesterol 4.8 (4.0–5.6)
Arthritis/cancer 3.4 (2.7–4.1)
Sex
Male
Arthritis/obesity 14.8 (12.1–17.5)
High blood pressure/high cholesterol 10.5 (8.4–12.6)
Asthma/obesity 9.4 (6.8–12.0)
Diabetes/obesity 7.2 (5.0–9.4)
High blood pressure/obesity 6.9 (5.1–8.6)
Female
Arthritis/obesity 16.4 (14.2–18.5)
High blood pressure/high cholesterol 7.9 (6.6–9.2)
Asthma/obesity 7.4 (5.7–9.1)
Arthritis/asthma 7.2 (5.6–8.8)
High blood pressure/obesity 6.2 (4.7–7.6)
Age, y
<65
Arthritis/obesity 16.7 (14.5–18.8)
Asthma/obesity 11.1 (9.1–13.2)
High blood pressure/high cholesterol 8.4 (6.9–9.8)
High blood pressure/obesity 7.8 (6.3–9.3)
Diabetes/obesity 6.4 (4.8–8.0)
≥65
Arthritis/obesity 12.9 (10.6–15.2)
High blood pressure/high cholesterol 11.1 (9.2–13.0)
Arthritis/cancer 7.01 (5.3–8.7)
Arthritis/high blood pressure 6.8 (5.2–8.4)
a Angina, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, high blood pressure, high cholesterol, myocardial in-
farction (heart attack), obesity, and stroke.
(continued on next page)
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(continued)
Table 2. Most Prevalent Chronic Conditiona Dyads by Age, Sex, and County for Delaware Adults with 2 Chronic Conditions, Behavioral Risk Factor Surveillance Sys-
tem, 2011–2014
Dyad % (95% Confidence Interval)
Arthritis/diabetes 6.2 (4.0−8.4)
County
Kent
Arthritis/obesity 16.1 (13.2–19.1)
Asthma/obesity 9.4 (6.5–12.2)
High blood pressure/obesity 8.8 (5.8–11.9)
High blood pressure/high cholesterol 8.3 (5.6–10.9)
Arthritis/asthma 6.5 (4.2–8.8)
New Castle
Arthritis/obesity 15.3 (12.8–17.8)
High blood pressure/high cholesterol 9.4 (7.7–11.2)
Asthma/obesity 8.3 (6.0–10.6)
High blood pressure/obesity 5.8 (4.3–7.3)
Arthritis/high blood pressure 5.5 (4.0–7.1)
Sussex
Arthritis/obesity 15.4 (12.4–18.4)
High blood pressure/high cholesterol 9.2 (7.3–11.1)
Asthma/obesity 8.1 (5.7–10.3)
High blood pressure/obesity 6.7 (4.6−8.8)
Arthritis/high cholesterol 6.5 (4.7–8.2)
a Angina, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, high blood pressure, high cholesterol, myocardial in-
farction (heart attack), obesity, and stroke.
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Table 3. Most Prevalent Chronic Conditiona Triads by Age, Sex and County for Delaware Adults with 3 or More Chronic Conditions, Behavioral Risk Factor Surveil-
lance System, 2011–2014
Triad % (95% Confidence Interval)
Total
Arthritis/high blood pressure/high cholesterol 7.7 (6.7–8.7)
Arthritis/asthma/obesity 7.2 (6.1–8.3)
Arthritis/diabetes/obesity 5.2 (4.4–6.1)
Arthritis/diabetes/high cholesterol 4.8 (4.1–5.5)
Arthritis/asthma/high cholesterol 4.2 (3.5–4.9)
High blood pressure/obesity/high cholesterol 4.1 (3.3–5.0)
Angina/heart attack/high cholesterol 3.1 (2.5–3.6)
Diabetes/high blood pressure/high cholesterol 3.1 (2.3–3.8)
Angina/heart attack/obesity 3.1 (2.3–3.8)
Arthritis/cancer/obesity 2.1 (1.5–2.7)
Sex
Male
Arthritis/high blood pressure/high cholesterol 7.5 (5.8–9.2)
High blood pressure/obesity/high cholesterol 5.7 (4.2–7.3)
Arthritis/diabetes/obesity 5.1 (3.8–6.2)
Arthritis/diabetes/high cholesterol 4.7 (3.5–5.9)
Angina/heart attack/obesity 4.5 (3.0–6.0)
Female
Arthritis/asthma/obesity 9.9 (8.1–11.6)
Arthritis/high blood pressure/high cholesterol 7.9 (6.7–9.1)
Arthritis/asthma/high cholesterol 6.6 (5.4–7.7)
Arthritis/diabetes/obesity 5.4 (4.2–6.6)
Arthritis/diabetes/high cholesterol 4.9 (4.0–5.8)
Age, y
<65
Arthritis/asthma/obesity 10.1 (8.3–11.8)
High blood pressure/obesity/high cholesterol 6.5 (5.1–7.9)
Arthritis/high blood pressure/high cholesterol 6.3 (4.9–7.7)
Arthritis/diabetes/obesity 5.1 (3.8–6.3)
Arthritis/diabetes/high cholesterol 4.5 (3.5–5.5)
≥65
Arthritis/high blood pressure/high cholesterol 9.7 (8.3–11.2)
Arthritis/diabetes/obesity 5.5 (4.4–6.6)
Arthritis/diabetes/high cholesterol 5.2 (4.2–6.2)
Angina/heart attack/high cholesterol 4.9 (3.8–6.0)
a Angina, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, high blood pressure, high cholesterol, myocardial in-
farction (heart attack), obesity and stroke.
(continued on next page)
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(continued)
Table 3. Most Prevalent Chronic Conditiona Triads by Age, Sex and County for Delaware Adults with 3 or More Chronic Conditions, Behavioral Risk Factor Surveil-
lance System, 2011–2014
Triad % (95% Confidence Interval)
Angina/heart attack/obesity 3.9 (2.5–5.2)
County
Kent
Arthritis/asthma/obesity 9.9 (7.5–12.3)
Arthritis/diabetes/obesity 6.4 (4.5–8.2)
Arthritis/high blood pressure/high cholesterol 5.7 (4.3–7.1)
Arthritis/diabetes/high cholesterol 5.6 (4.2–7.0)
Arthritis/asthma/high cholesterol 4.8 (3.3–6.2)
New Castle
Arthritis/high blood pressure/high cholesterol 8.5 (6.8–10.2)
Arthritis/asthma/obesity 6.9 (5.4–8.6)
Arthritis/diabetes/obesity 5.4 (4.0–6.8)
High blood pressure/obesity/high cholesterol 4.6 (3.3–6.0)
Arthritis/asthma/high cholesterol 4.4 (3.3–5.5)
Sussex
Arthritis/high blood pressure/high cholesterol 7.7 (6.2–9.2)
Arthritis/asthma/obesity 6.1 (4.3–7.8)
Arthritis/diabetes/high cholesterol 5.1 (3.7–6.3)
Arthritis/diabetes/obesity 4.2 (3.1–5.3)
Angina/heart attack/high cholesterol 3.9 (2.8–5.1)
a Angina, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, high blood pressure, high cholesterol, myocardial in-
farction (heart attack), obesity and stroke.
PREVENTING CHRONIC DISEASE VOLUME 13, E160
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY   NOVEMBER 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2016/16_0264.htm • Centers for Disease Control and Prevention       9
